Clinical Research Directory

Inclusion Criteria: 1. Aged 18-75 years old at time of consent. 2. Post-lingually deafened. 3. Bilaterally or unilaterally implanted with Oticon Medical Neuro ZTI cochlear implant, using Crystalis with autoXDP (GMCI 'CAP') as the main program, at 500pps stimulation rate. For bilateral CI users, only first-implanted side will be tested. 4. Fluent in French as determined by the investigator. 5. Willing to participate and comply with requirements of the protocol 6. Willing and able to provide written informed consent. Exclusion Criteria: 1. Additional health complexities that would prevent or restrict participation in the evaluations, including significant visual impairment and/or cognitive impairment. 2. Subjects who have life sustaining devices (such as pacemakers). 3. NeuroZti Subjects with Antenna SD Type. 4. Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. 5. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. 6. Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation. 7. Pregnant or breastfeeding women. 8. Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by investigator or Sponsor to not impact this investigation).